|
|
News Breaks | | | | November 26, 2012 | | 08:03 EDT |  | VRX | Valeant announces publication of efinaconazole Phase III results
Valeant announced that the Journal of the American Academy of Dermatology has published the positive results from our two pivotal, international, multicenter, randomized, double-blind, vehicle-controlled studies. The only approved topical treatments are lacquers with very limited efficacy. Valeant investigated the safety and efficacy of efinaconazole 10% topical solution, the first triazole antifungal agent developed for distal lateral subungual onychomycosis. The study's primary endpoint was stringently defined as the complete cure rate at Week 52, which means that the target nail showed no clinical involvement and no evidence of fungus present by both KOH testing and a negative fungal culture. | |
|
News For VRX From The Last 14 Days Check below for free stories on VRX the last two weeks. |
|
|
| May 17, 2013 | | 14:48 EDT |  | VRX | Actavis may bid for Warner Chilcott to ward off takeover, Reuters says
 Subscribe for More Information | | | 13:56 EDT | | VRX | Actavis may purchase Warner Chilcott as takeover defense, Reuters reports
Over past few weeks, Actavis (ACT) has "spurned approaches" from Valeant (VRX) and Mylan (MYL), and has instead pursued a bid for Warner Chilcott (WCRX), according to Reuters, citing people familiar with the situation. | | | May 15, 2013 | | 19:37 EDT | | VRX | Novartis weighing Actavis bid, WSJ reports
Subscribe for More Information | | | May 14, 2013 | | 17:48 EDT | | VRX | Lone Pine gives quarterly update on stakes
NEW STAKES: Valeant Pharmaceuticals (VRX), Virgin Media (VMED), Thermo Fisher Scientific (TMO), CME Group (CME), and Liberty Media (LMCA). INCREASED STAKES: Mead Johnson Nutrition (MJN), News Corp (NWSA), Intuitive Surgical (ISRG), Monsanto (MON), and Qualcomm (QCOM). DECREASED STAKES: Cognizant Technology Solutions (CTSH), Equinix (EQIX), Ralph Lauren (RL), Disney (DIS), and Oceaneering International (OII). LIQUIDATED STAKES: Facebook (FB), Crown Castle (CCI), Accretive Health (AH), Informatica (INFA), and NetEase (NTES). | | | 13:55 EDT | | VRX | Actavis weighing over $5B bid for Warner Chilcott, snubbed Mylan, Bloomberg says
Subscribe for More Information | | | May 10, 2013 | | 17:03 EDT | | VRX | Valeant announces information regarding continuance proposal
Subscribe for More Information | |
|
|
|
|
|
|
